It induces CD8+ T cells antitumor immunity, decreases the percentage of Tregs in the tumor, increases the levels of interferon-gamma (IFNγ) and reduces those of IL-6, IL-10, and VEGF, as shown in renal tumor model (Chen et al. 2015). This evidence concerns the gene CD8A and neoplasm.